Company Analysis

NextCure, Inc. (NXTC)

Nasdaq: NXTC · Pharmaceutical Preparations · Beltsville, MD · filing with the SEC since 2016
Grade5.5
◀ Past 5.4● Present 5.4▶ Future 5.6
5 est.

Filings

240 filings since 2017 beside 159 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 41 days after the quarter ended. The proxy statement was last filed Apr 24, 2026.

Filings a yearinsider forms included
8044532738425460
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 5 times in the last 36 months, the newest Oct 30, 2026.Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest Feb 3, 2025.SEC letters: 3 in the last 36 months, the newest Dec 9, 2025.
Insider forms 159

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 10, 2026 10-Q Quarterly report Sep 30, 2026
Nov 10, 2026 8-K items 2.02, 9.01 Results released · Current report
Nov 6, 2026 EFFECT Registration effective
Nov 6, 2026 424B3 Shelf offering
Nov 6, 2026 S-4/A Merger or exchange registration, amended
Nov 2, 2026 S-4/A Merger or exchange registration, amended
Oct 30, 2026 8-K item 5.02 Officer or director change · Current report Oct 26, 2026
Oct 20, 2026 SCHEDULE 13G Large holder notice
Oct 1, 2026 S-4/A Merger or exchange registration, amended
Sep 25, 2026 425 Merger communication
Sep 25, 2026 8-K items 8.01, 9.01 Other event · Current report Sep 21, 2026
Sep 3, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report
Aug 18, 2026 S-4 Merger or exchange registration
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 14, 2026 SCHEDULE 13G Large holder notice
Aug 13, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 12, 2026 SCHEDULE 13G Large holder notice
Aug 10, 2026 425 Merger communication
Aug 6, 2026 10-Q Quarterly report Jun 30, 2026
Aug 6, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 4, 2026 425 Merger communication
Jul 16, 2026 425 Merger communication
Jul 14, 2026 425 Merger communication
Jun 25, 2026 8-K items 5.02, 5.07, 9.01 Officer or director change; Shareholder vote · Current report Jun 18, 2026
Jun 1, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
May 13, 2026 SCHEDULE 13G/A Large holder update, amended
May 7, 2026 10-Q Quarterly report Mar 31, 2026
May 7, 2026 8-K items 2.02, 9.01 Results released · Current report
May 6, 2026 SCHEDULE 13G/A Large holder update, amended
Apr 24, 2026 DEFA14A Extra proxy material
Apr 24, 2026 DEF 14A Proxy statement Jun 18, 2026
Mar 5, 2026 10-K Annual report Dec 31, 2025
Mar 5, 2026 8-K items 2.02, 9.01 Results released · Current report
Mar 5, 2026 SCHEDULE 13D/A Activist holder update, amended
Feb 17, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 17, 2026 SCHEDULE 13G Large holder notice
Feb 13, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 12, 2026 SCHEDULE 13G Large holder notice
40 of 240 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton NXTC · research, not advice